Cantel Medical's Mar Cor Purification Subsidiary Acquires Eagle
Pure Water Systems, Inc.
LITTLE FALLS, N.J.,
Jan. 7, 2013 /PRNewswire/
-- CANTEL MEDICAL CORP. (NYSE: CMN), through its Mar
Cor Purification subsidiary, has continued the expansion of its
water purification and filtration segment by purchasing the assets
of Pennsylvania-based Eagle Pure
Water Systems, Inc. Eagle Pure Water provides water treatment
services for laboratory, industrial and medical customers in the
Philadelphia area. The acquired
business had pre-acquisition revenues of approximately $0.5 million. This cash deal is expected to
be modestly accretive to Cantel's earnings per share in fiscal year
2013 and beyond.
Curtis Weitnauer, President and
CEO of Mar Cor Purification, stated, "Adding Eagle Pure Water's
business and its strategic Philadelphia market presence to Mar Cor's
leadership position in medical water enables us to better serve our
national customers and further expand our business into the
laboratory and research segments. We expect to drive incremental
growth with the addition of Mar Cor's capabilities and broad
portfolio of products and services."
Greg Comitz, Founder and
President of Eagle Pure Water, has entered into a long-term
employment agreement with Mar Cor Purification, where he will
assist in the integration and continued service of the Eagle Pure
Water customer base.
About Eagle Pure Water Systems, Inc.
Started in the 1990s, Eagle Pure Water services water systems,
conducts installation and testing, offers ion exchange resin
regeneration, and provides equipment services. Eagle Pure Water has
developed a reputation of providing high quality service to
prominent healthcare, laboratory and industrial customers.
About Mar Cor Purification, Inc.
A subsidiary of Cantel Medical Corp., Mar Cor Purification is
dedicated to providing innovative solutions through filtration,
water, and disinfection technologies to the medical, life science
and industrial marketplaces. Mar Cor Purification has service
offices in 19 cities in the U.S. and Canada, with 7 resin regeneration plants
strategically located in Atlanta,
Boston, Chicago, Philadelphia, San
Antonio, Montreal and
Toronto. For more information
please visit http://www.mcpur.com.
About Cantel Medical Corp.
Cantel Medical Corp. (NYSE:CMN) is a leading provider of
infection prevention and control products in the healthcare market.
Our products include water purification equipment, sterilants,
disinfectants and cleaners, specialized medical device reprocessing
systems for endoscopy and renal dialysis, disposable infection
control products primarily for dental and GI endoscopy markets,
dialysate concentrates and other dialysis supplies, hollow fiber
membrane filtration and separation products for medical and
non-medical applications, and specialty packaging for infectious
and biological specimens. We also provide technical maintenance for
our products and offer compliance training services for the
transport of infectious and biological specimens.
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These statements involve a number of risks and uncertainties,
including, without limitation, the risks detailed in Cantel's
filings and reports with the Securities and Exchange Commission.
Such forward-looking statements are only predictions, and actual
events or results may differ materially from those projected or
anticipated.
SOURCE Cantel Medical Corp.